유방 임플란트 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 형상별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Breast Implants Market Summary

The global breast implants market size was estimated at USD 2.85 billion in 2025 and is projected to reach USD 5.16 billion by 2033, growing at a CAGR of 7.71% from 2026 to 2033. The market's growth is driven by rising demand for aesthetic enhancement procedures, technological advancements in implant materials, and increased awareness of body contouring solutions.

Growing social acceptance of cosmetic surgeries, coupled with the effect of media and celebrity culture, has encouraged more women to opt for breast augmentation. In addition, the availability of minimally invasive techniques and improved implant safety profiles has significantly reduced the hesitation around undergoing such procedures. The latest innovations in breast implant technology are significantly driving market growth by offering improved aesthetic outcomes and enhanced safety. Advanced implants in 2025 feature highly cohesive silicone gels that provide a more natural shape, better feel, and increased durability, reducing the risk of rupture and the likelihood of revision surgeries. Newer designs also incorporate thinner, customizable shells that conform more naturally to the body, resulting in better mobility and a more lifelike appearance. These improvements enhance patient satisfaction and broaden the appeal of breast augmentation procedures.

The increasing number of breast reconstruction surgeries is playing a significant role in driving the growth of the breast implants market. This trend is largely driven by the rising incidence of breast cancer, which requires mastectomy procedures, creating a strong need for reconstructive solutions to restore breast shape and appearance. As awareness about post-mastectomy reconstruction improves, more patients are opting for implant-based procedures to enhance their physical recovery and psychological well-being. In addition, advancements in surgical techniques and implant design have made reconstruction procedures safer, more effective, and aesthetically appealing, encouraging higher adoption. Supportive healthcare policies and improved access to reconstructive care in hospitals and specialized centers have further strengthened this trend, positioning breast implants as a critical component in comprehensive breast cancer treatment and recovery pathways.

"Although it is elective, aesthetic cosmetic surgery is an actual surgery that involves risks and possible side effects. Safety should be the priority, and we encourage patients to choose a board-certified, specialized plastic surgeon, trained and experienced in the procedure."-Dr. Naveen Cavale, Chair of the ISAPS Communications Committee and plastic surgeon in the UK

The rising prevalence of breast cancer is a key driver fueling the growth of the breast implants market, as it directly increases the demand for reconstructive surgeries following mastectomy. As breast cancer remains one of the leading causes of cancer-related morbidity among women globally, the number of women undergoing mastectomies has grown, resulting in a higher adoption of breast reconstruction procedures using implants. With improved survival rates due to early diagnosis and advanced treatment, more patients are opting for reconstruction to restore their physical appearance and emotional well-being. In addition, increasing awareness about reconstructive options and favorable reimbursement policies in many regions supports the use of implants as a restorative solution, thereby significantly driving market expansion.

The multiple benefits of breast implants drive market growth. Beyond aesthetic enhancement, breast implants contribute significantly to a woman's physical and emotional well-being. They help boost self-confidence and restore breast shape and size that may have changed due to aging, pregnancy, hormonal shifts, or previous surgeries, such as a mastectomy. In addition, breast implants offer a reliable solution for correcting asymmetry between breasts and allow individuals to achieve their desired breast size, tailored to personal preferences. As awareness of these benefits grows and surgical techniques become safer and more refined, more women are considering breast augmentation and reconstruction, thereby fueling the demand for breast implants.

The launch of new breast implant products is a significant driver of market growth, as it brings innovation, enhanced safety, and broader customization options to meet diverse patient needs. Advanced breast implants now offer features such as high-strength cohesive gels, ergonomic designs, lightweight materials, and improved biocompatibility, enhancing both aesthetic outcomes and patient comfort. These new offerings appeal to a broader demographic, including women seeking more natural results or undergoing post-mastectomy reconstruction.

Global Breast Implants Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global breast implants market report on the basis of product, shape, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Silicone Breast Implants
• Saline Breast Implants
• Shape Outlook (Revenue, USD Million, 2021 - 2033)
• Round
• Anatomical
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Reconstructive Surgery
• Cosmetic Surgery
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
  • 1.13.1. Commodity flow analysis (Model 1)
  • 1.13.2. Approach 1: Commodity flow approach
  • 1.13.3. Volume price analysis (Model 2)
  • 1.13.4. Approach 2: Volume price analysis
• 1.14. List of Secondary Sources
• 1.15. List of Primary Sources
• 1.16. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast Implants Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing number of breast augmentation procedures
    • 3.2.1.2. Rising incidence of breast cancer
    • 3.2.1.3. Introduction of technologically advanced products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of implant procedure
    • 3.2.2.2. Post-surgical complications
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Rising demand for cosmetic procedures
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Risks of complications
• 3.3. Breast Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Breast Implants Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Breast Implants Market: Product Movement Analysis & Market Share, 2025 & 2033
• 4.3. Silicone Breasts Implants
  • 4.3.1. Silicone Breasts Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Saline Breasts Implants
  • 4.4.1. Saline Breasts Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Implants Market: Shape Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Breast Implants Market: Shape Movement Analysis & Market Share, 2025 & 2033
  • 5.2.1. Round
    • 5.2.1.1. Round Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.2.2. Anatomical
    • 5.2.2.1. Anatomical Market Estimates and Forecasts 2021 to 2033, (USD Million)

Chapter 6. Breast Implants Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Breast Implants Market: Application Movement Analysis & Market Share, 2025 & 2033
• 6.3. Cosmetic Surgery
  • 6.3.1. Cosmetic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Reconstructive Surgery
  • 6.4.1. Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast Implants Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Breast Implants Market: End Use Movement Analysis & Market Share, 2025 & 2033
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Ambulatory Surgery Centers
  • 7.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Cosmetology Clinics
  • 7.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Breast Implants Market: Regional Estimates & Trend Analysis by Product, Shape, Application, End Use

• 8.1. Regional Outlook
• 8.2. Breast Implants Market: Regional Movement Analysis & Market Share, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. U.S. Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Canada Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Scenario
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Mexico Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. UK Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Germany Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. France Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Italy Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Spain Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Denmark Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Reimbursement Scenario
    • 8.4.8.5. Sweden Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Reimbursement Scenario
    • 8.4.9.5. Norway Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Japan Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. China Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. India Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. Reimbursement Scenario
    • 8.5.5.5. South Korea Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Reimbursement Scenario
    • 8.5.6.5. Australia Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Reimbursement Scenario
    • 8.5.7.5. Thailand Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Brazil Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Argentina Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. South Africa Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Saudi Arabia Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. Reimbursement Scenario
    • 8.7.4.5. UAE Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Reimbursement Scenario
    • 8.7.5.5. Kuwait Breast Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. ALLERGAN (AbbVie)
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Product Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. GC Aesthetics
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Product Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. SEBBIN
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Product Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. Mentor Worldwide LLC (Johnson & Johnson)
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Product Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Sientra Inc. (Tiger Aesthetics Medical, LLC)
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Product Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. POLYTECH Health & Aesthetics GmbH
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Product Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Establishment Labs S.A.
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Product Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. Shanghai Kangning Medical Supplies Ltd.
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Product Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. Guangzhou Wanhe Plastic Materials Co., Ltd.
    • 9.2.9.1. Company Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Product Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. HansBioMed
    • 9.2.10.1. Company Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Product Benchmarking
    • 9.2.10.4. Strategic Initiatives
  • 9.2.11. Bimini Health Tech.
    • 9.2.11.1. Company Overview
    • 9.2.11.2. Financial Performance
    • 9.2.11.3. Product Benchmarking
    • 9.2.11.4. Strategic Initiatives
• 9.3. Heat Map Analysis/ Company Market Position Analysis
• 9.4. Estimated Company Market Share Analysis, 2025